120 related articles for article (PubMed ID: 36417367)
1. Neurocognitive outcomes at age 5 years after prophylactic hydrocortisone in infants born extremely preterm.
Trousson C; Toumazi A; Bourmaud A; Biran V; Baud O
Dev Med Child Neurol; 2023 Jul; 65(7):926-932. PubMed ID: 36417367
[TBL] [Abstract][Full Text] [Related]
2. Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age.
Baud O; Trousson C; Biran V; Leroy E; Mohamed D; Alberti C;
JAMA; 2017 Apr; 317(13):1329-1337. PubMed ID: 28384828
[TBL] [Abstract][Full Text] [Related]
3. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic hydrocortisone in extremely preterm infants and brain MRI abnormality.
Alison M; Tilea B; Toumazi A; Biran V; Mohamed D; Alberti C; Bourmaud A; Baud O;
Arch Dis Child Fetal Neonatal Ed; 2020 Sep; 105(5):520-525. PubMed ID: 31980445
[TBL] [Abstract][Full Text] [Related]
5. Association between Baseline Cortisol Serum Concentrations and the Effect of Prophylactic Hydrocortisone in Extremely Preterm Infants.
Renolleau C; Toumazi A; Bourmaud A; Benoist JF; Chevenne D; Mohamed D; Alberti C; Biran V; Baud O;
J Pediatr; 2021 Jul; 234():65-70.e3. PubMed ID: 33359303
[TBL] [Abstract][Full Text] [Related]
6. The beneficial effect of prophylactic hydrocortisone treatment in extremely preterm infants improves upon adjustment of the baseline characteristics.
Baud O; Lehert P;
Pediatr Res; 2024 Jan; 95(1):251-256. PubMed ID: 37653218
[TBL] [Abstract][Full Text] [Related]
7. Placental Findings and Effect of Prophylactic Hydrocortisone in Extremely Preterm Infants.
Héneau A; Guimiot F; Mohamed D; Rideau Batista Novais A; Alberti C; Baud O;
Pediatrics; 2018 Feb; 141(2):. PubMed ID: 29348196
[TBL] [Abstract][Full Text] [Related]
8. Early low-dose hydrocortisone: is the neurodevelopment affected?
Ofman G; Perez M; Farrow KN
J Perinatol; 2018 Jun; 38(6):636-638. PubMed ID: 29467523
[TBL] [Abstract][Full Text] [Related]
9. Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia.
Watterberg KL; Walsh MC; Li L; Chawla S; D'Angio CT; Goldberg RN; Hintz SR; Laughon MM; Yoder BA; Kennedy KA; McDavid GE; Backstrom-Lacy C; Das A; Crawford MM; Keszler M; Sokol GM; Poindexter BB; Ambalavanan N; Hibbs AM; Truog WE; Schmidt B; Wyckoff MH; Khan AM; Garg M; Chess PR; Reynolds AM; Moallem M; Bell EF; Meyer LR; Patel RM; Van Meurs KP; Cotten CM; McGowan EC; Hines AC; Merhar S; Peralta-Carcelen M; Wilson-Costello DE; Kilbride HW; DeMauro SB; Heyne RJ; Mosquera RA; Natarajan G; Purdy IB; Lowe JR; Maitre NL; Harmon HM; Hogden LA; Adams-Chapman I; Winter S; Malcolm WF; Higgins RD;
N Engl J Med; 2022 Mar; 386(12):1121-1131. PubMed ID: 35320643
[TBL] [Abstract][Full Text] [Related]
10. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
[TBL] [Abstract][Full Text] [Related]
11. Two-year neurodevelopmental outcomes of extremely preterm infants treated with early hydrocortisone: treatment effect according to gestational age at birth.
Baud O; Trousson C; Biran V; Leroy E; Mohamed D; Alberti C;
Arch Dis Child Fetal Neonatal Ed; 2019 Jan; 104(1):F30-F35. PubMed ID: 29321180
[TBL] [Abstract][Full Text] [Related]
12. Effect of systemic hydrocortisone in ventilated preterm infants on parent-reported behavioural outcomes at 2 years' corrected age: follow-up of a randomised clinical trial.
Halbmeijer NM; Onland W; Cools F; Swarte RM; van der Heide-Jalving M; Dijk P; Mulder-de Tollenaer S; Tan RNGB; Mohns T; Bruneel E; van Heijst AFJ; Kramer B; Debeer A; van Weissenbruch MM; Marechal Y; Blom H; Plaskie K; Offringa M; van Wassenaer-Leemhuis AG; van Kaam AH; Aarnoudse-Moens CSH;
Arch Dis Child Fetal Neonatal Ed; 2023 Jul; 108(4):373-379. PubMed ID: 36593110
[TBL] [Abstract][Full Text] [Related]
13. Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan.
Onland W; Merkus MP; Nuytemans DH; Jansen-van der Weide MC; Holman R; van Kaam AH;
Trials; 2018 Mar; 19(1):178. PubMed ID: 29523175
[TBL] [Abstract][Full Text] [Related]
14. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
[TBL] [Abstract][Full Text] [Related]
15. Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial.
Marc I; Piedboeuf B; Lacaze-Masmonteil T; Fraser W; Mâsse B; Mohamed I; Qureshi M; Afifi J; Lemyre B; Caouette G; Bartholomew J; Nuyt AM; Julien P; Synnes A; Lucas M; Perreault T; Strueby L; Cieslak Z; Yusuf K; Pelligra G; Massé E; Larsen B; de Cabo C; Ruth C; Khurshid F; Lavoie PM
JAMA; 2020 Jul; 324(2):157-167. PubMed ID: 32662862
[TBL] [Abstract][Full Text] [Related]
16. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001145. PubMed ID: 29063594
[TBL] [Abstract][Full Text] [Related]
17. Neurodevelopmental Outcomes Among Extremely Preterm Infants 6.5 Years After Active Perinatal Care in Sweden.
Serenius F; Ewald U; Farooqi A; Fellman V; Hafström M; Hellgren K; Maršál K; Ohlin A; Olhager E; Stjernqvist K; Strömberg B; Ådén U; Källén K;
JAMA Pediatr; 2016 Oct; 170(10):954-963. PubMed ID: 27479919
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease.
Lodygensky GA; Rademaker K; Zimine S; Gex-Fabry M; Lieftink AF; Lazeyras F; Groenendaal F; de Vries LS; Huppi PS
Pediatrics; 2005 Jul; 116(1):1-7. PubMed ID: 15995023
[TBL] [Abstract][Full Text] [Related]
19. Pilot randomized trial of hydrocortisone in ventilator-dependent extremely preterm infants: effects on regional brain volumes.
Parikh NA; Kennedy KA; Lasky RE; McDavid GE; Tyson JE
J Pediatr; 2013 Apr; 162(4):685-690.e1. PubMed ID: 23140612
[TBL] [Abstract][Full Text] [Related]
20. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
